Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Hair Growth Supplement and Treatment Market

Hair Growth Supplement and Treatment Market Share

Report ID: GMI9725
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Hair Growth Supplement and Treatment Market Share

The competitive landscape of the market is characterized by the presence of both established nutraceutical and pharmaceutical companies that manufacture advanced hair growth supplement and pharmaceutical treatment products vying for market share. Key players are engaging in strategic initiatives such as collaboration, product launch, investment, and partnerships to strengthen their product portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for hair growth supplement and treatment.

Hair Growth Supplement and Treatment Market Companies

Prominent players operating in the market are as mentioned below:

Hair supplements
- Amway Corporation
- GNC Holdings, Inc.
- HUM Nutrition
- Nature’s Bounty
- Nutraceutical Wellness, Inc.
- OUAI Healthcare
- Phyto
- Viviscal Limited (Church & Dwight Co., Inc.)
Hair treatment
- Cipla Limited
- Curallux, LLC
- Eli Lilly, and Company
- ExoCoBio, Inc
- Keranique
- Lexington International
- Merck & Co., Inc.
- Pfizer, Inc.
- Rogaine (Johnson & Johnson)

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Hair growth supplement and treatment market size was USD 7.8 billion in 2023 and is expected to register 6.1% CAGR from 2024-2032 owing to the increasing prevalence of hair disorders such as alopecia areata, telogen effluvium, and other scalp conditions worldwide.

The pharmaceuticals segment reached USD 5.6 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to increasing incidence of hair loss conditions such as androgenetic alopecia and alopecia areata.

North America hair growth supplement and treatment industry held 44.5% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to companies investing heavily in research and development and distribution in the region.

Amway Corporation, GNC Holdings, Inc., HUM Nutrition, Nature